Submissions for variant NM_000350.3(ABCA4):c.1958G>T (p.Arg653Leu)

dbSNP: rs141823837

Total submissions: 3

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Invitae	RCV003768465	SCV004640349	likely pathogenic	not provided	2022-12-07	criteria provided, single submitter	clinical testing	In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg653 amino acid residue in ABCA4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23776498, 28559085). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function. ClinVar contains an entry for this variant (Variation ID: 635441). This missense change has been observed in individual(s) with clinical features of Stargardt Disease (Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 653 of the ABCA4 protein (p.Arg653Leu).
Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare	RCV000786893	SCV000925792	likely pathogenic	Cone-rod dystrophy 3	2018-11-05	no assertion criteria provided	clinical testing
Sharon lab, Hadassah-Hebrew University Medical Center	RCV001002840	SCV001160861	likely pathogenic	Stargardt disease	2019-06-23	no assertion criteria provided	research